Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for ARetinal tissue knockout to study efflux of cholesterol (AGCA1/G1 double KO - TY and LysM cre) (Study ST000681)

C18 POSITIVE ION MODE (Analysis AN001049)

Metabolite	Structure	F1	F2	F3	F4	F5
TG 44:1; [M+NH4]+@9.80	ME189707	1.34	0.87	0.73	2.18	0.73
TG 53:1; [M+NH4]+@10.94	ME189732	1.32	0.77	0.73	2.32	0.81
TG 48:3; [M+NH4]+@9.89	ME189714	0.85	2.06	0.82	0.67	0.56
PC 34:4; [M+Na]+@5.63	ME189648	1.04	0.61	0.79	0.49	1.87
TG 58:1; [M+NH4]+@11.55	ME189748	0.76	1.18	1.56	0.94	0.22
TG 56:0; [M+NH4]+@11.50	ME189741	1.30	0.92	0.95	0.11	1.07
TG 60:13; [M+NH4]+@9.76	ME189758	0.70	1.56	1.02	1.20	0.75
TG 50:3; [M+NH4]+@10.20	ME189720	1.12	1.51	0.82	0.83	0.69
DG 40:4; [M+NH4]+@8.43	ME189640	1.17	1.42	0.74	0.97	0.79
TG 48:2; [M+NH4]+@10.16	ME189713	1.26	1.29	0.80	0.97	0.71
PE 46:10; [M+H]+@6.88	ME189687	0.98	1.54	0.73	1.21	0.87
DG 35:1; [M+NH4]+@8.20	ME189630	1.05	1.47	0.82	1.33	0.66
TG 50:4; [M+NH4]+@9.96	ME189721	1.12	1.36	0.82	1.21	0.71
TG 46:2; [M+NH4]+@9.81	ME189711	1.20	1.14	0.74	1.61	0.82
TG 44:2; [M+NH4]+@9.55	ME189708	1.28	0.73	0.85	1.78	0.89
TG 54:1; [M+NH4]+@11.06	ME189733	1.37	0.65	0.93	1.52	0.80
TG 51:1; [M+NH4]+@10.71	ME189723	1.19	0.81	1.10	1.21	0.69
plasmenyl-PE 42:4; [M+H]+@8.15	ME189799	1.40	0.91	0.82	1.30	0.75
lysoPC 19:0; [M+Na]+@2.92	ME189771	1.16	0.79	0.88	1.52	1.03
SM 34:1; [M]+@5.83	ME189692	1.16	0.83	0.93	1.15	1.03
TG 54:6; [M+NH4]+@10.15	ME189738	1.16	0.78	0.95	1.26	1.00
DG 36:0; [M+NH4]+@8.88	ME189631	1.29	0.74	0.90	1.39	0.90
plasmenyl-PE 40:4; [M+H]+@7.68	ME189796	1.26	0.87	0.87	1.31	0.89
TG 58:9; [M+NH4]+@10.17	ME189755	1.21	0.90	0.90	1.25	0.92
TG 49:2; [M+NH4]+@10.28	ME189716	1.58	0.87	0.87	0.97	0.57
TG 49:1; [M+NH4]+@10.49	ME189715	1.46	0.53	1.07	0.96	0.76
lysoPE 18:0; [M+H]+@2.50	ME189776	1.38	0.84	0.95	0.79	0.81
PC 42:10; [M+Na]+@5.78	ME189656	1.30	0.82	0.96	0.83	0.91
lysoPE 16:0; [M+H]+@1.66	ME189775	1.41	0.74	0.85	1.04	0.95
lysoPC 16:1; [M+H]+@1.39	ME189768	1.54	0.73	0.84	0.96	0.83
lysoPC 18:0; [M+Na]+@2.27	ME189769	1.46	0.77	0.90	0.86	0.82
lysoPE 22:6; [M+H]+@1.32	ME189780	1.48	0.74	0.84	0.89	0.92
lysoPC 22:5; [M+Na]+@1.57	ME189774	1.39	0.68	1.03	0.58	0.89
lysoPC 20:1; [M+H]+@2.56	ME189772	1.40	0.57	1.09	0.69	0.84
lysoPE 18:1; [M+H]+@1.85	ME189777	1.34	0.65	1.07	0.80	0.85
SM 33:1; [M+Na]+@5.55	ME189690	1.50	0.62	0.90	0.72	0.96
TG 52:0; [M+NH4]+@11.02	ME189724	1.34	0.68	0.92	0.71	1.09
plasmenyl-PE 36:2; [M+H]+@7.34	ME189790	1.15	0.93	1.09	0.68	0.82
DG 36:1; [M+NH4]+@8.48	ME189632	1.27	0.93	1.07	0.63	0.72
PC 32:3; [M+H]+@6.05	ME189647	1.29	0.80	1.07	0.66	0.80
TG 50:0; [M+NH4]+@10.79	ME189717	1.25	0.89	1.03	0.62	0.86
TG 46:1; [M+NH4]+@10.09	ME189710	1.40	1.13	0.84	0.72	0.70
TG 53:0; [M+NH4]+@11.16	ME189731	1.36	1.05	0.88	0.78	0.73
lysoPC 16:0; [M+H]+@1.59	ME189767	1.48	0.82	0.95	0.71	0.72
plasmenyl-PC 18:0; [M+Na]+@1.68	ME189781	1.52	0.77	0.95	0.70	0.74
lysoPC 22:4; [M+H]+@1.91	ME189773	1.58	0.93	0.81	0.58	0.76
PC 38:4; [M+H]+@8.85	ME189651	1.54	0.90	0.87	0.55	0.76
SM 30:1; [M]+@4.41	ME189688	0.99	1.16	1.22	0.46	0.67
TG 58:5; [M+NH4]+@10.80	ME189751	1.07	1.30	1.05	0.72	0.62
DG 36:2; [M+NH4]+@8.10	ME189633	1.09	1.41	0.99	0.58	0.62
SM 34:0; [M+Na]+@6.16	ME189691	1.18	1.31	0.96	0.49	0.69
SM 32:2; [M+Na]+@4.55	ME189689	0.72	1.24	1.05	0.91	1.08
TG 58:11; [M+NH4]+@9.81	ME189750	0.69	1.23	1.22	0.92	0.83
TG 50:5; [M+NH4]+@9.76	ME189722	0.76	1.48	0.97	0.58	1.01
plasmenyl-PC 34:2; [M+Na]+@6.72	ME189785	1.02	1.30	0.95	0.60	0.88
TG 64:16; [M+NH4]+@9.76	ME189763	0.90	1.36	0.98	0.84	0.87
DG 34:0; [M+NH4]+@8.40	ME189628	1.01	1.25	0.93	0.89	0.90
PE 42:7; [M+H]+@7.01	ME189685	0.96	1.22	1.00	0.78	0.90
DG 36:3; [M+NH4]+@7.76	ME189634	0.88	1.05	0.99	1.45	0.98
PE 40:8; [M+H]+@5.97	ME189682	1.00	0.99	0.85	1.28	1.17
PC 40:9; [M+Na]+@5.49	ME189655	0.98	1.02	0.85	1.37	1.13
PC 48:6; [M+Na]+@8.48	ME189660	0.99	1.04	0.88	1.40	1.04
DG 36:4; [M+NH4]+@7.53	ME189635	0.70	1.19	0.94	1.47	1.15
TG 58:10; [M+NH4]+@10.05	ME189749	0.86	1.17	0.89	1.67	0.98
DG 38:4; [M+NH4]+@8.05	ME189637	0.98	1.22	0.97	1.27	0.77
TG 42:0; [M+NH4]+@9.78	ME189706	0.84	1.19	1.14	1.27	0.69
SM 34:2; [M+Na]+@5.33	ME189693	0.71	1.25	0.99	1.17	1.09
TG 66:18; [M+NH4]+@9.68	ME189764	0.69	1.15	1.07	1.23	1.08
PC 35:4; [M+Na]+@5.99	ME189650	0.76	1.07	1.11	1.26	0.98
TG 64:15; [M+NH4]+@9.86	ME189762	0.78	1.24	0.99	1.32	0.96
PE 40:7; [M+H]+@6.37	ME189681	0.83	1.17	0.99	1.26	0.99
PE 42:8; [M+H]+@6.52	ME189686	0.85	1.16	0.98	1.26	0.98
DG 38:5; [M+NH4]+@7.66	ME189638	0.82	1.28	0.88	1.22	1.09
TG 56:9; [M+NH4]+@9.87	ME189747	0.94	1.30	0.88	1.02	0.97
TG 60:12; [M+NH4]+@9.97	ME189757	0.93	1.26	0.90	1.19	0.94
TG 52:5; [M+NH4]+@10.06	ME189729	1.05	1.03	0.84	0.99	1.18
TG 62:14; [M+NH4]+@9.82	ME189761	0.83	1.02	0.98	1.11	1.20
DG 38:6; [M+NH4]+@7.44	ME189639	0.82	0.96	1.07	1.03	1.16
PE 38:7; [M+H]+@5.98	ME189676	0.83	0.92	1.09	1.14	1.12
DG 42:10; [M+NH4]+@7.06	ME189642	0.78	0.99	1.24	0.93	0.93
TG 54:7; [M+NH4]+@10.03	ME189739	0.85	0.97	1.18	0.92	0.95
PE 36:6; [M+H]+@5.62	ME189670	0.84	0.99	1.12	1.09	0.99
PE 37:6; [M+H]+@5.99	ME189671	0.92	0.89	1.11	0.94	1.05
SM 36:2; [M]+@6.01	ME189696	0.85	0.95	1.11	1.00	1.07
PE 38:2; [M+H]+@7.58	ME189672	0.90	0.93	1.11	1.02	1.01
SM 42:2; [M+Na]+@7.82	ME189704	0.91	0.96	1.08	0.97	1.04
PE 42:5; [M+H]+@7.65	ME189684	1.24	0.99	0.82	1.11	0.94
TG 50:1; [M+NH4]+@10.58	ME189718	1.27	0.76	0.99	1.02	0.89
PC 30:1; [M+Na]+@5.49	ME189645	1.25	0.79	0.97	1.16	0.87
TG 48:1; [M+NH4]+@10.35	ME189712	1.31	0.84	0.90	1.11	0.87
PE 42:11; [M+Na]+@5.44	ME189683	1.25	0.89	0.91	0.95	0.95
TG 46:0; [M+NH4]+@10.34	ME189709	1.21	0.87	0.93	1.01	0.96
lysoPC 14:0; [M+H]+@1.14	ME189765	1.15	0.78	1.04	1.04	0.94
PC 40:8; [M+H]+@6.45	ME189654	1.14	0.83	1.04	0.99	0.92
lysoPE 18:2; [M+H]+@1.37	ME189778	1.21	0.79	0.98	0.94	0.97
SM 37:1; [M]+@6.90	ME189697	1.15	0.86	1.00	0.91	0.97
TG 52:3; [M+NH4]+@10.45	ME189727	0.95	1.02	1.06	0.77	1.03
SM 40:1; [M+Na]+@7.78	ME189700	1.01	0.91	1.06	0.87	1.02
PC 35:2; [M+Na]+@6.64	ME189649	0.97	1.01	1.05	0.92	0.97
PE 40:5; [M+H]+@7.11	ME189679	0.96	1.00	1.07	0.88	0.96
DG 34:2; [M+NH4]+@7.61	ME189629	0.90	1.12	1.00	0.94	1.03
plasmenyl-PC 36:3; [M+Na]+@6.77	ME189786	1.05	1.00	0.98	0.93	1.00
PC 50:6; [M+Na]+@8.95	ME189661	0.99	1.01	0.97	1.03	1.05
TG 56:4; [M+NH4]+@10.77	ME189742	0.99	1.01	0.97	1.01	1.05
DG 40:6; [M+NH4]+@7.97	ME189641	0.99	0.89	1.04	1.13	1.00
plasmenyl-PE 36:1; [M+H]+@7.75	ME189789	1.05	0.92	1.00	1.11	0.98
plasmenyl-PE 40:6; [M+H]+@7.21	ME189798	1.01	0.92	1.04	1.00	0.99
plasmenyl-PE 42:6; [M+H]+@7.78	ME189800	1.01	0.82	1.09	1.04	1.00
PE 40:6; [M+H]+@6.88	ME189680	0.99	1.02	1.03	1.05	0.94
PE 36:4; [M+H]+@6.34	ME189668	1.08	0.93	1.02	1.05	0.92
PE 38:4; [M+H]+@7.01	ME189673	1.06	0.97	1.01	1.05	0.91
PE 40:4; [M+H]+@7.42	ME189678	1.08	0.96	1.02	1.03	0.88
MG 17:0; [M+Li]+@3.15	ME189644	1.02	0.97	1.06	1.03	0.89
TG 54:5; [M+NH4]+@10.32	ME189737	1.04	1.00	1.05	1.05	0.85
TG 54:2; [M+NH4]+@10.87	ME189734	1.03	1.03	1.05	0.94	0.87
PC 42:11; [M+Na]+@5.36	ME189657	1.14	0.88	1.04	0.92	0.90
SM 35:1; [M]+@6.22	ME189694	1.14	0.94	1.03	0.89	0.86
PC 32:0; [M+H]+@6.59	ME189646	1.07	0.90	1.06	0.96	0.93
lysoPC 19:0; [M+H]+@2.94	ME189770	1.10	0.93	1.05	0.94	0.87
plasmenyl-PE 40:5; [M+H]+@7.33	ME189797	1.05	0.97	1.06	0.95	0.88
plasmenyl-PE 36:4; [M+H]+@6.69	ME189791	1.07	0.96	1.04	0.93	0.90
plasmenyl-PE 38:6; [M+H]+@6.58	ME189795	1.07	0.95	1.04	0.92	0.93
PE 34:1; [M+H]+@6.86	ME189664	1.05	0.93	1.11	0.90	0.86
PE 36:2; [M+H]+@7.00	ME189667	1.05	0.93	1.05	0.90	0.96
PE 34:2; [M+H]+@6.43	ME189665	1.03	0.91	1.11	0.87	0.92
plasmenyl-PE 38:5; [M+H]+@6.88	ME189794	1.04	0.95	1.07	0.86	0.92
TG 56:5; [M+NH4]+@10.61	ME189743	1.22	1.01	0.98	0.95	0.75
lysoPE 20:4; [M+H]+@1.38	ME189779	1.15	0.96	1.06	0.92	0.76
TG 52:1; [M+NH4]+@10.80	ME189725	1.18	0.96	1.03	0.90	0.79
TG 56:6; [M+NH4]+@10.48	ME189744	1.20	0.92	0.99	1.06	0.81
plasmenyl-PC 20:0; [M+Na]+@2.59	ME189782	1.19	1.05	0.93	1.03	0.80
TG 58:8; [M+NH4]+@10.37	ME189754	1.11	1.06	0.95	1.04	0.86
TG 58:6; [M+NH4]+@10.72	ME189752	1.01	1.13	1.08	0.93	0.75
DG 38:3; [M+NH4]+@8.31	ME189636	1.04	1.17	1.05	0.80	0.76
TG 54:3; [M+NH4]+@10.67	ME189735	1.06	1.09	1.04	0.84	0.82
TG 56:8; [M+NH4]+@10.10	ME189746	1.12	1.06	0.89	0.88	1.01
PC 40:5; [M+H]+@7.60	ME189653	1.04	1.08	1.02	0.77	0.91
TG 52:4; [M+NH4]+@10.23	ME189728	1.06	1.11	0.97	0.82	0.91
PE 21:4; [M+H]+@1.42	ME189662	1.10	0.94	1.05	0.80	0.91
PE 38:5; [M+H]+@6.54	ME189674	1.08	1.00	1.01	0.84	0.93
SM 36:1; [M]+@6.71	ME189695	1.10	1.04	1.01	0.83	0.87
DG 32:0; [M+NH4]+@7.88	ME189627	1.20	1.00	0.97	0.79	0.86
PC 42:9; [M+H]+@6.86	ME189659	1.16	0.97	1.04	0.80	0.81
TG 50:2; [M+NH4]+@10.39	ME189719	1.18	1.12	0.92	0.81	0.84
plasmenyl-PE 34:0; [M+H]+@7.66	ME189787	1.14	1.05	0.96	0.91	0.86
plasmenyl-PE 38:4; [M+H]+@7.27	ME189793	1.15	1.08	0.95	0.87	0.85
PC 42:4; [M+Na]+@7.85	ME189658	1.02	1.01	1.16	1.18	0.63
TG 58:7; [M+NH4]+@10.53	ME189753	1.03	1.09	1.06	1.09	0.74
SM 42:1; [M+Na]+@8.32	ME189703	1.02	1.10	0.96	1.01	0.94
TG 52:6; [M+NH4]+@9.81	ME189730	1.00	1.10	0.97	1.09	0.93
TG 60:10; [M+NH4]+@10.33	ME189756	1.00	1.13	0.96	1.07	0.91
PE 38:6; [M+H]+@6.17	ME189675	0.93	1.09	1.01	1.09	0.95
TG 62:12; [M+NH4]+@10.24	ME189760	0.95	1.07	1.05	1.13	0.88
TG 52:2; [M+NH4]+@10.61	ME189726	0.97	0.96	1.05	1.33	0.89
TG 62:11; [M+NH4]+@10.32	ME189759	1.00	1.04	0.98	1.24	0.91
TG 54:4; [M+NH4]+@10.48	ME189736	1.05	0.92	1.04	1.16	0.89
plasmenyl-PE 36:0; [M+H]+@8.22	ME189788	1.02	1.02	1.02	1.15	0.88
TG 56:7; [M+NH4]+@10.27	ME189745	0.99	0.98	1.04	1.20	0.89
lysoPC 15:0; [M+H]+@1.40	ME189766	1.05	0.57	1.22	0.87	1.04
PE 34:3; [M+H]+@5.91	ME189666	1.17	0.65	1.26	0.75	0.76
plasmenyl-PE 36:5; [M+H]+@6.34	ME189792	0.86	0.70	1.29	0.67	1.12
SM 37:2; [M]+@6.45	ME189698	0.77	0.70	1.38	0.71	1.06
SM 41:2; [M]+@7.71	ME189702	0.73	1.00	1.19	0.61	1.17
SM 39:1; [M]+@7.54	ME189699	0.91	1.03	1.11	0.63	1.02
PE 39:6; [M+H]+@6.61	ME189677	1.03	0.98	1.11	0.59	0.92
plasmenyl-PC 34:1; [M+Na]+@7.14	ME189784	0.99	1.00	1.08	0.57	1.01
DG 44:12; [M+NH4]+@6.99	ME189643	1.11	0.82	1.06	0.59	1.06
SM 41:1; [M]+@8.11	ME189701	0.98	0.81	1.09	0.78	1.15
TG 54:8; [M+NH4]+@9.71	ME189740	0.96	0.93	1.06	0.71	1.13
PC 38:7; [M+Na]+@5.66	ME189652	1.03	0.85	1.13	0.74	0.97
PE 32:1; [M+H]+@6.26	ME189663	1.03	0.83	1.09	0.78	1.05
SM 44:2; [M]+@8.36	ME189705	0.88	0.86	1.18	0.72	1.09
PE 36:5; [M+H]+@5.92	ME189669	0.96	0.79	1.22	0.73	0.99
plasmenyl-PC 32:0; [M+Na]+@7.04	ME189783	0.96	0.82	1.18	0.72	1.02

Factors:

F1	CRE:LysM Cre \| SEX:f
F2	CRE:negative \| SEX:f
F3	CRE:negative \| SEX:m
F4	CRE:Tyrosinase Cre \| SEX:f
F5	CRE:Tyrosinase Cre \| SEX:m

Data matrix